trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Corvetta D et al. Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: functional and therapeutic implications. 2013 J. Biol. Chem. pmid:23362253
Dhawan D et al. DNMT1: an emerging target in the treatment of invasive urinary bladder cancer. 2013 Urol. Oncol. pmid:22609058
Oikawa M et al. RNAi-mediated knockdown of Xist does not rescue the impaired development of female cloned mouse embryos. 2013 J. Reprod. Dev. pmid:23363561
Dagnas M et al. HDAC inhibition facilitates the switch between memory systems in young but not aged mice. 2013 J. Neurosci. pmid:23365234
Fernandez G et al. Targeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins. 2013 J. Virol. pmid:23365428
Meng F et al. Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer. 2013 Br. J. Cancer pmid:23370212
Wang Z et al. Arabidopsis paired amphipathic helix proteins SNL1 and SNL2 redundantly regulate primary seed dormancy via abscisic acid-ethylene antagonism mediated by histone deacetylation. 2013 Plant Cell pmid:23371947
Horvat T et al. Reversibility of membrane N-glycome of HeLa cells upon treatment with epigenetic inhibitors. 2013 PLoS ONE pmid:23336012
Li H et al. Epigenetic regulation of CXCR4 expression by the ocular microenvironment. 2013 Invest. Ophthalmol. Vis. Sci. pmid:23188729
Gill RK et al. Regulation of intestinal serotonin transporter expression via epigenetic mechanisms: role of HDAC2. 2013 Am. J. Physiol., Cell Physiol. pmid:23195070
Wessels I et al. Activation of IL-1β and TNFα genes is mediated by the establishment of permissive chromatin structures during monopoiesis. 2013 Immunobiology pmid:23195574
Wunder T et al. Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infection. 2013 Cancer Gene Ther. pmid:23196273
Oliveira CS et al. HDAC inhibition decreases XIST expression on female IVP bovine blastocysts. 2013 Reproduction pmid:23104973
Lakshmi SV et al. Oxidative stress in coronary artery disease: epigenetic perspective. 2013 Mol. Cell. Biochem. pmid:23160801
Kuno A et al. Resveratrol improves cardiomyopathy in dystrophin-deficient mice through SIRT1 protein-mediated modulation of p300 protein. 2013 J. Biol. Chem. pmid:23297412
Seuter S et al. Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1α,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression. 2013 Nucleic Acids Res. pmid:23093607
Jin H et al. HDAC inhibitor trichostatin A promotes proliferation and odontoblast differentiation of human dental pulp stem cells. 2013 Tissue Eng Part A pmid:23013422
Luo Y et al. High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy. 2013 Eur. J. Cancer pmid:23040637
Culley KL et al. Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation. 2013 Arthritis Rheum. pmid:23575963
Sato T et al. Enhancement of inflammatory protein expression and nuclear factor Κb (NF-Κb) activity by trichostatin A (TSA) in OP9 preadipocytes. 2013 PLoS ONE pmid:23555753
Mateen S et al. Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells. 2013 J. Pharmacol. Exp. Ther. pmid:23461975
Chambliss AB et al. Simultaneously defining cell phenotypes, cell cycle, and chromatin modifications at single-cell resolution. 2013 FASEB J. pmid:23538711
Wang YG et al. Mechanisms of trichostatin A inhibiting AGS proliferation and identification of lysine-acetylated proteins. 2013 World J. Gastroenterol. pmid:23745024
Guo SW et al. Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis. 2013 Fertil. Steril. pmid:22999795
Pitta CA et al. Reversal of ER-β silencing by chromatin modifying agents overrides acquired tamoxifen resistance. 2013 Cancer Lett. pmid:23752064
Zhang C et al. Decreased PADI4 mRNA association with global hypomethylation in hepatocellular carcinoma during HBV exposure. 2013 Cell Biochem. Biophys. pmid:22907585
Van Beneden K et al. Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis. 2013 Toxicol. Appl. Pharmacol. pmid:23707763
Meng F et al. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3. 2013 Int. J. Oncol. pmid:23709006
Liu Y et al. MCM-2 is a therapeutic target of Trichostatin A in colon cancer cells. 2013 Toxicol. Lett. pmid:23770000
Welch MD et al. Hypomethylation of the CTGF gene locus is a common feature of paediatric pre-B acute lymphoblastic leukaemia. 2013 Br. J. Haematol. pmid:23772794
Aseem O et al. Cubilin expression is monoallelic and epigenetically augmented via PPARs. 2013 BMC Genomics pmid:23773363
Wang H et al. Histone deacetylase inhibitors facilitate partner preference formation in female prairie voles. 2013 Nat. Neurosci. pmid:23727821
Humphreys KJ et al. Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster. 2013 Mol. Carcinog. pmid:22308110
Gao B et al. Inhibition of histone deacetylase activity suppresses IFN-γ induction of tripartite motif 22 via CHIP-mediated proteasomal degradation of IRF-1. 2013 J. Immunol. pmid:23729439
Luo B et al. A possible strategy to produce pigs resistant to porcine reproductive and respiratory syndrome virus. 2013 Antiviral Res. pmid:23732571
Tigges J et al. Aryl hydrocarbon receptor repressor (AhRR) function revisited: repression of CYP1 activity in human skin fibroblasts is not related to AhRR expression. 2013 J. Invest. Dermatol. pmid:22951721
Spallotta F et al. A nitric oxide-dependent cross-talk between class I and III histone deacetylases accelerates skin repair. 2013 J. Biol. Chem. pmid:23463510
Chandwani S et al. Induction of DARPP-32 by brain-derived neurotrophic factor in striatal neurons in vitro is modified by histone deacetylase inhibitors and Nab2. 2013 PLoS ONE pmid:24204683
Liesz A et al. Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. 2013 J. Neurosci. pmid:24174668
Wu DS et al. Epigallocatechin-3-gallate and trichostatin A synergistically inhibit human lymphoma cell proliferation through epigenetic modification of p16INK4a. 2013 Oncol. Rep. pmid:24064951
Al-Nakhle H et al. Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region. 2013 Int. J. Oncol. pmid:24068253
Yu CW et al. Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease. 2013 J. Med. Chem. pmid:23905680
Chikamatsu K et al. Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck. 2013 Cancer Sci. pmid:23992541
Oksenych V et al. Histone methyltransferase DOT1L drives recovery of gene expression after a genotoxic attack. 2013 PLoS Genet. pmid:23861670
BurlibaÅŸa L and Zarnescu O In vivo effects of Trichostatin A - A histone deacetylase inhibitor - On chromatin remodeling during Triturus cristatus spermatogenesis. 2013 Anim. Reprod. Sci. pmid:24100069
Kang KA et al. Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity. 2013 Int. J. Oncol. pmid:24100442
Moldrich RX et al. Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice. 2013 Behav. Brain Res. pmid:24103642
Fujiki R et al. A proapoptotic effect of valproic acid on progenitors of embryonic stem cell-derived glutamatergic neurons. 2013 Cell Death Dis pmid:23788034
Chang X et al. DNA methylation of NDRG2 in gastric cancer and its clinical significance. 2013 Dig. Dis. Sci. pmid:23010743
Li KK et al. MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3). 2013 Brain Pathol. pmid:23227829
Matsubara K et al. Dynamics and regulation of lysine-acetylation during one-cell stage mouse embryos. 2013 Biochem. Biophys. Res. Commun. pmid:23567968
Contreras AU et al. Deacetylation of p53 induces autophagy by suppressing Bmf expression. 2013 J. Cell Biol. pmid:23629966
Duo J et al. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line. 2013 DNA Cell Biol. pmid:23451817
Chen CQ et al. Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases. 2013 Carcinogenesis pmid:23430957
Han B et al. Trichostatin A stabilizes the expression of pluripotent genes in human mesenchymal stem cells during ex vivo expansion. 2013 PLoS ONE pmid:24312356
Choi S et al. Histone deacetylases inhibitor trichostatin A modulates the extracellular release of APE1/Ref-1. 2013 Biochem. Biophys. Res. Commun. pmid:23665318
Katsuno M et al. [Dysfunction of dynactin 1 in motor neuron degeneration]. 2013 Rinsho Shinkeigaku pmid:24291886
Wang YJ et al. Histone acetylation in the olfactory bulb of young rats facilitates aversive olfactory learning and synaptic plasticity. 2013 Neuroscience pmid:23262233
Diao JS et al. Histone deacetylase inhibitor reduces hypertrophic scarring in a rabbit ear model. 2013 Plast. Reconstr. Surg. pmid:23806955
Sharma A et al. Trichostatin-A modulates claudin-1 mRNA stability through the modulation of Hu antigen R and tristetraprolin in colon cancer cells. 2013 Carcinogenesis pmid:23880304
Oliveira CS et al. Supplementation with the histone deacetylase inhibitor trichostatin A during in vitro culture of bovine embryos. 2013 Zygote pmid:21867598
Wang P et al. Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function. 2013 Neurotoxicology pmid:23558232
Joosten M et al. Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype. 2013 Haematologica pmid:22899583
Krause M et al. Probing the compressibility of tumor cell nuclei by combined atomic force-confocal microscopy. 2013 Phys Biol pmid:24304807
Frame FM et al. HDAC inhibitor confers radiosensitivity to prostate stem-like cells. 2013 Br. J. Cancer pmid:24220693
Jagirdar K et al. The NR4A2 nuclear receptor is recruited to novel nuclear foci in response to UV irradiation and participates in nucleotide excision repair. 2013 PLoS ONE pmid:24223135
Liu Y et al. Expression loss and revivification of RhoB gene in ovary carcinoma carcinogenesis and development. 2013 PLoS ONE pmid:24223801
Lee AR et al. Nicotinamide: a class III HDACi delays in vitro aging of mouse oocytes. 2013 J. Reprod. Dev. pmid:23474603
Chatterjee N et al. Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cells. 2013 Cancer Biol. Ther. pmid:23792638
Zych J et al. The epigenetic modifiers 5-aza-2'-deoxycytidine and trichostatin A influence adipocyte differentiation in human mesenchymal stem cells. 2013 Braz. J. Med. Biol. Res. pmid:23797495
Guo LH et al. The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer. 2013 Int J Mol Sci pmid:23880861
Jo SJ et al. Valproic acid promotes human hair growth in in vitro culture model. 2013 J. Dermatol. Sci. pmid:23810771
Huang L et al. Down-regulation of miR-301a suppresses pro-inflammatory cytokines in Toll-like receptor-triggered macrophages. 2013 Immunology pmid:23808420
Keuser B et al. Influences of histone deacetylase inhibitors and resveratrol on DNA repair and chromatin compaction. 2013 Mutagenesis pmid:23814181
Lim SY et al. Trichostatin A enhances differentiation of human induced pluripotent stem cells to cardiogenic cells for cardiac tissue engineering. 2013 Stem Cells Transl Med pmid:23884641
Shim SH et al. Histone deacetylase inhibitors suppress coxsackievirus B3 growth in vitro and myocarditis induced in mice. 2013 Acta Virol. pmid:24294962
Yan G et al. Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells. 2013 Mol. Carcinog. pmid:22290509
Asthana J et al. Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells. 2013 J. Biol. Chem. pmid:23798680
Gundersen B Pair-bonding through epigenetics. 2013 Nat. Neurosci. pmid:23799469
Feng T et al. Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2). 2013 Bioorg. Med. Chem. pmid:23820574
Lopez-Atalaya JP et al. Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition. 2013 Nucleic Acids Res. pmid:23821663
Okada T et al. Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas. 2013 Cancer Sci. pmid:23829175
Cong P et al. Effects of trichostatin A on histone acetylation and methylation characteristics in early porcine embryos after somatic cell nuclear transfer. 2013 Anim. Sci. J. pmid:23607426
Munro SK et al. Histone deacetylase inhibition by trichostatin A mitigates LPS induced TNFα and IL-10 production in human placental explants. 2013 Placenta pmid:23623485
Lee MS et al. Stabilization of p21 (Cip1/WAF1) following Tip60-dependent acetylation is required for p21-mediated DNA damage response. 2013 Cell Death Differ. pmid:23238566
Kamiya H et al. Enhanced transgene expression from chromatinized plasmid DNA in mouse liver. 2013 Int J Pharm pmid:23247018
Yang L et al. Trichostatin A inhibits transforming growth factor-β-induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced NF-E2-related factor 2-antioxidant response element signaling. 2013 Mol. Pharmacol. pmid:23284002
Zhang S et al. Effect of trichostatin A and paclitaxel on the proliferation and apoptosis of lung adenocarcinoma cells. 2013 Chin. Med. J. pmid:23286491
Gao C et al. Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex. 2013 Blood pmid:23287862
Marek L et al. Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells. 2013 J. Med. Chem. pmid:23252603
Li KK et al. MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L. 2013 Brain Pathol. pmid:23252729
Seuter S et al. The gene for the transcription factor BHLHE40/DEC1/stra13 is a dynamically regulated primary target of the vitamin D receptor. 2013 J. Steroid Biochem. Mol. Biol. pmid:23220548
Singh T et al. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo. 2013 Epigenetics pmid:23221619
Montero-Melendez T et al. Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors. 2013 Cell Death Differ. pmid:23222458
McBrian MA et al. Histone acetylation regulates intracellular pH. 2013 Mol. Cell pmid:23201122
Shi H et al. Synergistic induction of miR-126 by hypoxia and HDAC inhibitors in cardiac myocytes. 2013 Biochem. Biophys. Res. Commun. pmid:23201405
Hutz JE et al. The multidimensional perturbation value: a single metric to measure similarity and activity of treatments in high-throughput multidimensional screens. 2013 J Biomol Screen pmid:23204073
Nakazawa Y et al. Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytes. 2013 J. Immunother. pmid:23211626
Tavakoli-Yaraki M et al. Induction of apoptosis by Trichostatin A in human breast cancer cell lines: involvement of 15-Lox-1. 2013 Tumour Biol. pmid:23055198
Chen CQ et al. Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer. 2013 Mol. Cell. Biochem. pmid:23867991